Insights and News Curated for Life Science Experts by Life Science Experts....

INSIGHTS HUB

Warren Buffett’s hiring philosophy has long been quoted in business circles, and for good reason. As he prepares to step down as CEO of...

As Life Sciences recruiting becomes more selective and AI has continued advancement, incorporating these technologies into recruitment...

In a landmark decision, the Federal Trade Commission (FTC) has voted 3-2 to approve the issuance of a final rule that could reshape the...

Redmond, WA, July 1, 2024 (Radiant) -- Radiant Vision Systems has appointed Stone Jiang as their new CEO, succeeding Doug Kreysar who...

Rahway, NJ, July 1, 2024 (Business Wire) -- Merck (NYSE: MRK), known as MSD outside the U.S. and Canada, and Orion Corporation...

North Chicago, IL, July 1, 2024 (PRNewswire) -- AbbVie has named Robert A. Michael as its new CEO and board member, effective. He takes...

London, July 3, 2024 (Reuters) -- In a strategic move to enhance its mRNA technology portfolio, British pharmaceutical giant GSK has...

South San Francisco, CA, June 18, 2024 (Business Wire) -- Marea Therapeutics, raises $190 million from leading investors, to pioneer...

New Orleans, LA, June 14, 2024 (Indian Pharma Post) -- AxoSim, a life science firm specializing in lab-grown human brains, has...

San Mateo, CA and San Diego, June 18, 2024 (Globe Newswire) -- Belharra Therapeutics and Sanofi have partnered to discover novel small...

The Woodlands, TX, June 17, 2024 (Globe Newswire) -- Autonomix Medical, Inc. has appointed Brad Hauser as its new President and Chief...

Marlborough, MA, June 18, 2024 (PRNewswire) -- In a significant addition to its vascular portfolio, Boston Scientific is aqcuiring Silk...

Seattle, WA, June 4, 2024 (Globe newswire) -- VILYA, Inc. (Vilya), a biotechnology company pioneering a new class of medicines with...

Philadelphia, PA, May 30, 2024 (Globe Newswire) -- Vanessa Wolfeler will take over as CEO of SERB Pharmaceuticals on June 3, 2024....

Rahway, NJ, and New York, May 29, 2024 (Business Wire) -- Merck is acquiring EyeBio, a biotech company focused on eye diseases, in a...